Kévin Ahrweiller1,2, J F Houvenaghel3,4, A Riou3,4, S Drapier3,4, P Sauleau3,5, C Haegelen6,7, P Jannin7, M Vérin3,4, X Palard3,8, F Le Jeune3,8. 1. "Behavior and Basal Ganglia" Research Unit, University of Rennes 1, Rennes, France. kevin.ahrweiller@gmail.com. 2. Department of Neurology, University Hospital of Rennes, Rennes, France. kevin.ahrweiller@gmail.com. 3. "Behavior and Basal Ganglia" Research Unit, University of Rennes 1, Rennes, France. 4. Department of Neurology, University Hospital of Rennes, Rennes, France. 5. Department of Neurophysiology, University Hospital of Rennes, Rennes, France. 6. Department of Neurosurgery, University Hospital of Rennes, Rennes, France. 7. MediCIS" Laboratory, INSERM/University of Rennes 1, Rennes, France. 8. Department of Nuclear Medicine, Eugene Marquis Hospital Centre, University Hospital of Rennes, Rennes, France.
Abstract
INTRODUCTION: Patients with Parkinson's disease sometimes report postural instability and gait disorders (PIGD) after subthalamic nucleus deep brain stimulation (STN-DBS). Whether this is the direct consequence of DBS or the result of natural disease progression is still subject to debate. OBJECTIVE: To compare changes in brain metabolism during STN-DBS between patients with and without PIGD after surgery. METHODS: We extracted consecutive patients from a database where all Rennes Hospital patients undergoing STN-DBS are registered, with regular prospective updates of their clinical data. Patients were divided into two groups (PIGD and No PIGD) according to changes after surgery, as measured with a composite score based on the selected Unified Parkinson's Disease Rating Scale items. All patients underwent positron emission tomography with 18[F]-fluorodeoxyglucose 3 months before and after surgery. We ran an ANOVA with two factors (group: PIGD vs. No PIGD; and phase: preoperative vs. postoperative) on SPM8 to compare changes in brain metabolism between the two groups. RESULTS: Participants were 56 patients, including 10 in the PIGD group. The two groups had similar baseline (i.e., before surgery) characteristics. We found two clusters of increased metabolism in the PIGD group relative to the No PIGD group: dorsal midbrain/pons, including locomotor mesencephalic region and reticular pontine formation, and right motor cerebellum. CONCLUSION: We found different metabolic changes during DBS-STN among patients with PIGD, concerning brain regions that are already known to be involved in gait disorders in Parkinson's disease, suggesting that DBS is responsible for the appearance of PIGD.
INTRODUCTION:Patients with Parkinson's disease sometimes report postural instability and gait disorders (PIGD) after subthalamic nucleus deep brain stimulation (STN-DBS). Whether this is the direct consequence of DBS or the result of natural disease progression is still subject to debate. OBJECTIVE: To compare changes in brain metabolism during STN-DBS between patients with and without PIGD after surgery. METHODS: We extracted consecutive patients from a database where all Rennes Hospital patients undergoing STN-DBS are registered, with regular prospective updates of their clinical data. Patients were divided into two groups (PIGD and No PIGD) according to changes after surgery, as measured with a composite score based on the selected Unified Parkinson's Disease Rating Scale items. All patients underwent positron emission tomography with 18[F]-fluorodeoxyglucose 3 months before and after surgery. We ran an ANOVA with two factors (group: PIGD vs. No PIGD; and phase: preoperative vs. postoperative) on SPM8 to compare changes in brain metabolism between the two groups. RESULTS:Participants were 56 patients, including 10 in the PIGD group. The two groups had similar baseline (i.e., before surgery) characteristics. We found two clusters of increased metabolism in the PIGD group relative to the No PIGD group: dorsal midbrain/pons, including locomotor mesencephalic region and reticular pontine formation, and right motor cerebellum. CONCLUSION: We found different metabolic changes during DBS-STN among patients with PIGD, concerning brain regions that are already known to be involved in gait disorders in Parkinson's disease, suggesting that DBS is responsible for the appearance of PIGD.
Entities:
Keywords:
Gait disorders; Parkinson’s disease; Positron emission tomography with 18[F]-fluorodeoxyglucose; Subthalamic nucleus deep brain stimulation
Authors: J L Lancaster; M G Woldorff; L M Parsons; M Liotti; C S Freitas; L Rainey; P V Kochunov; D Nickerson; S A Mikiten; P T Fox Journal: Hum Brain Mapp Date: 2000-07 Impact factor: 5.038
Authors: Anna L Bartels; Bauke M de Jong; Nir Giladi; Joanna D Schaafsma; R Paul Maguire; Lammy Veenma; Jan Pruim; Yacov Balash; Moussa B H Youdim; Klaus L Leenders Journal: Mov Disord Date: 2006-09 Impact factor: 10.338
Authors: M U Ferraye; B Debû; V Fraix; J Xie-Brustolin; S Chabardès; P Krack; A-L Benabid; P Pollak Journal: Neurology Date: 2008-04-15 Impact factor: 9.910
Authors: Manon Auffret; Florence Le Jeune; Anne Maurus; Sophie Drapier; Jean-François Houvenaghel; Gabriel Hadrien Robert; Paul Sauleau; Marc Vérin Journal: J Neurol Sci Date: 2016-12-02 Impact factor: 3.181
Authors: Carine Karachi; David Grabli; Frédéric A Bernard; Dominique Tandé; Nicolas Wattiez; Hayat Belaid; Eric Bardinet; Annick Prigent; Hans-Peter Nothacker; Stéphane Hunot; Andreas Hartmann; Stéphane Lehéricy; Etienne C Hirsch; Chantal François Journal: J Clin Invest Date: 2010-07-12 Impact factor: 14.808
Authors: Bart F L van Nuenen; Rianne A J Esselink; Marten Munneke; Johhannes D Speelman; Teus van Laar; Bastiaan R Bloem Journal: Mov Disord Date: 2008-12-15 Impact factor: 10.338